Oral Biologic Shows Promise for Food Allergy Treatment

(MedPage Today) — PHILADELPHIA — Oral remibrutinib (Rhapsido) increased peanut tolerance in adults with proven allergy to it, with benefits in as little as 1 week, a phase II trial showed.
After 4 weeks on the Bruton’s tyrosine kinase (BTK…